Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, February 27th. Analysts expect Rapport Therapeutics to post earnings of ($0.62) per share for the quarter.
Rapport Therapeutics Stock Performance
Shares of RAPP stock opened at $12.68 on Friday. The stock’s fifty day moving average is $16.11 and its 200-day moving average is $19.85. Rapport Therapeutics has a 52 week low of $12.09 and a 52 week high of $29.74.
About Rapport Therapeutics
See Also
- Five stocks we like better than Rapport Therapeutics
- Using the MarketBeat Stock Split Calculator
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- 3 Ways To Invest In Coffee, Other Than Drinking It
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Use the MarketBeat Excel Dividend Calculator
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Rapport Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapport Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
